Crossmark

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Crossref DOI link: https://doi.org/10.1007/s00535-016-1290-1

Published Online: 2016-12-02

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Ogawa, Eiichi

Furusyo, Norihiro

Nomura, Hideyuki

Dohmen, Kazufumi

Higashi, Nobuhiko

Takahashi, Kazuhiro

Kawano, Akira

Azuma, Koichi

Satoh, Takeaki

Nakamuta, Makoto

Koyanagi, Toshimasa

Kato, Masaki

Shimoda, Shinji

Kajiwara, Eiji

Hayashi, Jun
License Information

License valid from 2016-12-02